Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COPAN is a global leader in the development and manufacture of specimen collection and transport systems for microbiology, as well as advanced laboratory automation. The company is best known for its patented FLOQSwabs technology, which revolutionized the field by significantly improving the uptake and release of clinical samples. COPAN's product portfolio includes the ESwab system for liquid-based microbiology and the WASPLab, a modular automation platform that integrates robotics and digital imaging to streamline laboratory workflows. Their solutions are essential for the diagnosis of infectious diseases, forensic analysis, and environmental testing. Headquartered in Italy with a major presence in the United States, COPAN serves clinical laboratories and healthcare providers worldwide. The company continues to innovate in the fields of digital microbiology and artificial intelligence-driven diagnostic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COPAN Systems.